Abstract: The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.
Type:
Grant
Filed:
November 2, 2015
Date of Patent:
August 11, 2020
Assignee:
Aurealis Oy
Inventors:
Thomas Wirth, Juha Yrjänheikki, Haritha Samaranayake, Dirk Weber, Igor Mierau, Peter Allard Bron, Herwig Bachmann